difference between tirzepatide and mounjaro (tirzepatide) - Diabetes & Wieght Loss Wegovy Tablets vs Mounjaro (Tirzepatide):

These recommendations are not generally applicable to individuals with diabetes due to other causes, for example monogenic diabetes, secondary diabetes and type 1 diabetes, or to children

As a GLP-1 agonist, Semaglutide has increasingly become recognized for its beneficial role in obesity treatment and cardiovascular health improvement

Weight changes: Still minimal

However, FDA said the responses were insufficient

10.1006/bbrc.2000.3763 75 LiD.-j.YueQ.LiuL.CheK.-k.LiuX.-m.HuC.-h

In contrast, neither treatment arm saw statistically significant improvements in fibrosis without worsening MASH in comparison with the placebo group